Key Pathways to Prevent Posttraumatic Arthritis for Future Molecule-Based Therapy
Open Access
- 8 May 2013
- journal article
- research article
- Published by SAGE Publications in CARTILAGE
- Vol. 4 (3_suppl) , 13S-21S
Abstract
Joint injuries are common, especially among young adults aged 18 to 44 years. They are accompanied by a cascade of events that increase the risk of posttraumatic osteoarthritis (PTOA). Therefore, understanding of biological responses that predispose to PTOA should help in determining treatment modalities to delay and/or prevent the onset and progression of the disease. The vast majority of the literature pointed to chondrocyte death and apoptosis, inflammation and matrix damage/fragmentation being the earliest events that follow joint trauma. Together these events lead to the development of osteoarthritis-like focal cartilage lesions that if untreated have a tendency to expand and progress to fully developed disease. Currently, the only treatments available for joint trauma are surgical interventions. Experimental biologic approaches involve engineering of cartilage with the use of cells (stem cells or chondrocytes), juvenile or adult cartilage pieces, scaffolds, and various polymeric matrices. The major challenge for all of them is regeneration of normal functional mature hyaline cartilage that can sustain the load, resist compression, and most important, integrate with the host tissue. If the tissue is spontaneously repaired it fails to reproduce original structure and function and thus, may be more susceptible to re-injury. Thus, there is a critical need to develop novel molecular mechanism-based therapeutic approaches to biologic chondral and/or osteochondral repair. The focus of this review is on the earliest molecular and cellular manifestations of injury that can be grouped based on the following therapeutic options for PTOA: chondroprotection, anti-inflammatory, matrix protection, and matrix remodeling/matrix synthesis.Keywords
This publication has 69 references indexed in Scilit:
- Post‐traumatic osteoarthritis: Improved understanding and opportunities for early interventionJournal of Orthopaedic Research, 2011
- Phase 1 safety and tolerability study of BMP-7 in symptomatic knee osteoarthritisBMC Musculoskeletal Disorders, 2010
- Rotenone prevents impact‐induced chondrocyte deathJournal of Orthopaedic Research, 2010
- Matrix metalloproteinase 13–deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte developmentArthritis & Rheumatism, 2009
- The impact of anterior cruciate ligament injury on lubricin metabolism and the effect of inhibiting tumor necrosis factor α on chondroprotection in an animal modelArthritis & Rheumatism, 2009
- Anti-apoptotic treatments prevent cartilage degradation after acute trauma to human ankle cartilageOsteoarthritis and Cartilage, 2009
- Biological impact of the fibroblast growth factor family on articular cartilage and intervertebral disc homeostasisGene, 2008
- OP-1/BMP-7 in cartilage repairInternational Orthopaedics, 2007
- Functional tissue engineering for tendon repair: A multidisciplinary strategy using mesenchymal stem cells, bioscaffolds, and mechanical stimulationJournal of Orthopaedic Research, 2007
- Osteoarthritis of the knee after injury to the anterior cruciate ligament or meniscus: the influence of time and ageOsteoarthritis and Cartilage, 1995